机译:中和骨桥蛋白抑制肥胖引起的炎症和胰岛素抵抗
Florian W. Kiefer,1 Maximilian Zeyda,1 Karina Gollinger,1 Birgit Pfau,1 Angelika Neuhofer,1 Thomas Weichhart,2 Marcus D. Säemann,2 René Geyeregger,1 Michaela Schlederer,3 Lukas Kenner,3'4 and Thomas M. Stulnig1From the 1 Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria, the 2 Clinical Division of Nephrology and Dialysis, Department of Medicine UI, Medical University of Vienna, Vienna, Austria, the 3 Ludwig Boltzmann Institute for Cancer Research, Medical University of Vienna, Vienna, Austria, and the 4 Department of Pathology, Medical University of Vienna, Vienna, AustriaCorresponding author Thomas M. Stulnig, thomas.stulnig@meduniwien.ac.at.Received 17 March 2009 and accepted 17 January 2010. Published ahead of print at http://diabetes.diabetesjaurnals.org on 27 January 2010. DOI: 10.2337/db09-0404.© 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.,;
机译:激活的STAT1(PIAS1)的蛋白抑制剂通过抑制脂肪组织中的炎症级联反应,防止肥胖引起的胰岛素抵抗
机译:髓样细胞限制的胰岛素受体缺陷可预防肥胖引起的炎症和全身性胰岛素抵抗
机译:骨髓细胞限制胰岛素受体缺陷可防止肥胖诱导的炎症和全身胰岛素抵抗力
机译:要进行对数转换或不进行对数转换:在以腹部肥胖作为炎症和胰岛素抵抗的预测因子的模型中,对数正态数据进行回归
机译:肥胖引起的炎症和胰岛素抵抗的发展:脂肪组织,脂肪酸和Toll样受体的作用。
机译:中和骨桥蛋白抑制肥胖引起的炎症和胰岛素抵抗
机译:中和骨桥蛋白抑制肥胖引起的炎症和胰岛素抵抗